Steward Partners Investment Solutions’s Vertex Pharmaceuticals VRTX Stock Holding History

Steward Partners Investment Solutions’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$205K	Buy	+491	New	+$208K	0.03%	247

Other funds holding VRTX

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Steward Partners Investment Solutions's VRTX Position: Q1 2024 in Review

Steward Partners Investment Solutions opened a new position in Vertex Pharmaceuticals (VRTX) in Q1 2024: 491 shares worth $205K. The stake represents 0.03% of the portfolio and ranks #247 among its holdings.

1,497 funds tracked by Wall St. Rank hold VRTX as of Q1 2024.

Steward Partners Investment Solutions held 491 shares of Vertex Pharmaceuticals worth $205K as of Q1 2024.
Vertex Pharmaceuticals was a new Steward Partners Investment Solutions position in Q1 2024.
Vertex Pharmaceuticals made up 0.03% of Steward Partners Investment Solutions's portfolio in Q1 2024, its #247 holding.
1,497 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2024.

Based on Steward Partners Investment Solutions's 13F filing for Q1 2024, filed 15 May 2024.